Colorectal Cancer: Competitive Landscape to 2026

Wednesday, June 6, 2018 Cancer News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, June 6, 2018 /PRNewswire/ -- Colorectal Cancer: Competitive Landscape to 2026SummaryRead the full

report: Colorectal cancer (CRC) is a cancer that originates in either the colon or the rectum.CRC is the fourth leading cause of mortality among cancer patients in the world, and is the third most diagnosed
cancer globally.Most cases of CRC present as adenocarcinomas, but other types of CRC include gastrointestinal carcinoid tumors, gastrointestinal stromal tumors, primary colorectal lymphoma, leiomyosarcoma, melanoma, and squamous cell carcinoma.As of May 2018, the CRC pipeline featured over 850 products across all stages of clinical development. EGFR and VEGF inhibitors remain a key focus of development, particularly in regards to biosimilar development.In 2016, there were around 76,000 diagnosed incident cases of CRC across the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and China); among these cases, the most (34%) were diagnosed at Stage II.China accounted for 34% of diagnosed incident cases of CRC in the 8MM in 2016, and will show the strongest growth in incident cases over 2016-2026 at an AGR of 5.6% due to its significantly increasing population.Overall, GlobalData expects new drug approvals with novel approaches to treatment to drive the CRC market growth over the next decade (2016-2026).Companies mentioned in this report: Roche, Merck,Bristol-Myers Squibb, Regeneron, Amgen, BoehringerIngelheim, Bayer, Eli Lilly, Array BioPHarma, Taiho Pharmacuetical, Ono Pharmaceutical, Mologen, Symphogen, Sumitomo Dainippon Pharma, DanDrit BiotechScopeGlobalData's Colorectal Cancer: Competitive Landscape to 2026 combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.Components of the slide deck include -- Pipeline Assessment-regional breakdown, promising late-stage products, early-stage pipeline by molecule type- Clinical Trials Assessment-trial breakdown by phase, leading industry and non-industry sponsors, enrollment analytics- Commercial Assessment-leading marketed products, current and future players- Competitive Landscape Analysis-key market events (2016-2026).Reasons to buy- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.- Develop business strategies by understanding the trends shaping and driving the global CRC market.- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global CRC market in the future.- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.Read the full report: About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:

SOURCE Reportlinker

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store